Pulse Biosciences IncNASDAQ:PLSE
- LAST PRICE7.8100
- TODAY'S CHANGE (%)-0.0800 (-1.0139%)
- Bid / Lots6.6900/ 2
- Ask / Lots8.0000/ 4
- Open / Previous Close7.9200 / 7.8900
- Day Range
- 52 Week Range
- Volume170,165
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PLSE |
|---|---|---|
| 09:32 ET | 3336 | 7.91 |
| 09:39 ET | 100 | 7.78 |
| 09:43 ET | 100 | 7.76 |
| 09:45 ET | 312 | 7.79 |
| 09:50 ET | 100 | 7.75 |
| 09:56 ET | 989 | 7.765 |
| 09:59 ET | 203 | 7.73 |
| 10:06 ET | 3315 | 7.85 |
| 10:08 ET | 100 | 7.85 |
| 10:19 ET | 633 | 7.8963 |
| 10:21 ET | 200 | 7.85 |
| 10:24 ET | 200 | 7.86 |
| 10:28 ET | 100 | 7.875 |
| 10:30 ET | 1100 | 7.955 |
| 10:32 ET | 296 | 7.942 |
| 10:35 ET | 100 | 7.91 |
| 10:39 ET | 1400 | 7.935 |
| 10:42 ET | 400 | 7.87 |
| 10:50 ET | 100 | 7.87 |
| 10:55 ET | 400 | 7.87 |
| 10:57 ET | 100 | 7.85 |
| 11:00 ET | 549 | 7.85 |
| 11:04 ET | 800 | 7.79 |
| 11:09 ET | 100 | 7.79 |
| 11:18 ET | 100 | 7.83 |
| 11:24 ET | 100 | 7.84 |
| 11:26 ET | 200 | 7.83 |
| 11:27 ET | 287 | 7.83 |
| 11:29 ET | 23051 | 7.87 |
| 11:31 ET | 500 | 7.9 |
| 11:36 ET | 426 | 7.9 |
| 11:40 ET | 100 | 7.87 |
| 11:42 ET | 100 | 7.85 |
| 11:47 ET | 200 | 7.84 |
| 11:56 ET | 200 | 7.84 |
| 11:58 ET | 300 | 7.81 |
| 12:00 ET | 2713 | 7.81 |
| 12:05 ET | 100 | 7.81 |
| 12:07 ET | 500 | 7.83 |
| 12:09 ET | 200 | 7.83 |
| 12:14 ET | 200 | 7.82 |
| 12:16 ET | 912 | 7.905 |
| 12:18 ET | 100 | 7.905 |
| 12:27 ET | 100 | 7.87 |
| 12:36 ET | 100 | 7.88 |
| 12:38 ET | 600 | 7.86 |
| 12:52 ET | 1100 | 7.89 |
| 12:54 ET | 464 | 7.86 |
| 12:56 ET | 100 | 7.86 |
| 12:57 ET | 300 | 7.88 |
| 12:59 ET | 100 | 7.86 |
| 01:01 ET | 100 | 7.86 |
| 01:10 ET | 200 | 7.86 |
| 01:12 ET | 4675 | 7.895 |
| 01:17 ET | 700 | 7.86 |
| 01:19 ET | 400 | 7.88 |
| 01:21 ET | 19702 | 7.87 |
| 01:24 ET | 600 | 7.865 |
| 01:26 ET | 700 | 7.85 |
| 01:28 ET | 2605 | 7.885 |
| 01:30 ET | 100 | 7.86 |
| 01:32 ET | 100 | 7.86 |
| 01:33 ET | 100 | 7.86 |
| 01:37 ET | 100 | 7.86 |
| 01:39 ET | 100 | 7.86 |
| 01:42 ET | 100 | 7.875 |
| 01:44 ET | 100 | 7.86 |
| 01:50 ET | 700 | 7.9 |
| 01:53 ET | 100 | 7.905 |
| 01:57 ET | 400 | 7.905 |
| 02:06 ET | 719 | 7.86 |
| 02:09 ET | 4934 | 7.85 |
| 02:18 ET | 100 | 7.82 |
| 02:24 ET | 12646 | 7.8 |
| 02:26 ET | 100 | 7.74 |
| 02:27 ET | 300 | 7.73 |
| 02:29 ET | 200 | 7.69 |
| 02:31 ET | 100 | 7.69 |
| 02:33 ET | 100 | 7.69 |
| 02:36 ET | 100 | 7.69 |
| 02:38 ET | 100 | 7.69 |
| 02:40 ET | 900 | 7.63 |
| 02:45 ET | 300 | 7.62 |
| 02:47 ET | 100 | 7.62 |
| 02:56 ET | 400 | 7.61 |
| 03:02 ET | 100 | 7.61 |
| 03:05 ET | 200 | 7.61 |
| 03:07 ET | 100 | 7.61 |
| 03:09 ET | 300 | 7.6 |
| 03:12 ET | 1600 | 7.66 |
| 03:14 ET | 428 | 7.69 |
| 03:16 ET | 126 | 7.7 |
| 03:18 ET | 757 | 7.7 |
| 03:20 ET | 400 | 7.705 |
| 03:23 ET | 100 | 7.72 |
| 03:25 ET | 400 | 7.74 |
| 03:32 ET | 2509 | 7.75 |
| 03:34 ET | 700 | 7.78 |
| 03:36 ET | 2912 | 7.83 |
| 03:38 ET | 959 | 7.77 |
| 03:39 ET | 100 | 7.77 |
| 03:41 ET | 100 | 7.79 |
| 03:43 ET | 1977 | 7.8 |
| 03:45 ET | 700 | 7.85 |
| 03:48 ET | 100 | 7.845 |
| 03:50 ET | 1733 | 7.81 |
| 03:52 ET | 300 | 7.82 |
| 03:54 ET | 5078 | 7.83 |
| 03:56 ET | 1400 | 7.81 |
| 03:57 ET | 2459 | 7.81 |
| 03:59 ET | 16876 | 7.81 |
May 16, 2024
May 14, 2024
Pulse Biosciences Enhances Executive Leadership Team, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow Jones
May 9, 2024
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System, from 8:00AM ET on Thursday May 09, 2024 by Dow Jones
8:00AM ET on Thursday May 09, 2024 by Dow Jones
May 7, 2024
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow Jones*DJ Pulse Biosciences 1Q Loss $10.1M >PLSE, from 4:05PM ET on Tuesday May 07, 2024 by Dow Jones
4:05PM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pulse Biosciences Inc | 431.3M | -9.6x | --- |
Heart Test Laboratories Inc | 457.0M | -14.2x | --- |
Cibus Inc | 456.7M | -1.0x | --- |
Nano-X Imaging Ltd | 566.3M | -9.1x | --- |
Orchestra Biomed Holdings Inc | 186.4M | -3.6x | --- |
MaxCyte Inc | 488.2M | -13.2x | --- |
Company Information
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Contact Information
- Headquarters
- 3957 Point Eden WayHAYWARD, CA, United States 94545-3720
- Phone
- 510-906-4600
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Robert Duggan
- President, Chief Executive Officer, Director
- Burke Barrett
- Chief Technology Officer, Director
- Darrin Uecker
- Chief Science Officer - Cardiac Surgery
- Niv Ad
- Chief Commercial Officer
- Kevin Danahy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $431.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.65 |
EPS | $-0.82 |
Book Value | $0.80 |
P/E Ratio | -9.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
